Amc Mental Health, Llc | |
263 Vietnam Veterans Highway Mangilao GU 96913 | |
(671) 647-8262 | |
(671) 647-5252 |
Full Name | Amc Mental Health, Llc |
---|---|
Speciality | Counselor |
Location | 263 Vietnam Veterans Highway, Mangilao, Guam |
Authorized Official Name and Position | Hoa Van Nguyen (PRESIDENT) |
Authorized Official Contact | 6716478262 |
Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
Mailing Address | Practice Location Address |
---|---|
Amc Mental Health, Llc 1244 N. Marine Corps Dr. Upper Tumon GU 96913 Ph: (671) 647-8262 | Amc Mental Health, Llc 263 Vietnam Veterans Highway Mangilao GU 96913 Ph: (671) 647-8262 |
NPI Number | 1700346541 |
---|---|
Provider Enumeration Date | 03/20/2019 |
Last Update Date | 03/20/2019 |
Identifier | Type | State | Issuer |
---|---|---|---|
1700346541 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
101Y00000X | Counselor | (* (Not Available)) | Primary |
106H00000X | Marriage & Family Therapist | (* (Not Available)) | Secondary |
News Archive
SCIENTISTS at the University of York have discovered how the prostate gland develops for the first time, according to research published today (Thursday, February 6) in Stem Cell Reports.
By knocking out a single gene in mice, immunologists at Duke University Medical Center have mimicked a little-understood autoimmune disorder in humans.
Microsulis Medical Limited, the leading company in microwave technology for medical devices, today announced that the U.S. Food and Drug Administration (FDA) has provided the company 510(k) clearance to market the Acculis Accu2i percutaneous microwave tissue ablation (pMTA) system for the coagulation of soft tissue during surgical procedures.
Merck reported today that investigators in the TRA-2P study of vorapaxar have been provided with additional information about the recommendations of the Data and Safety Monitoring Board (DSMB) regarding the TRA-2P study. The additional information was sent yesterday in a communication to investigators from the Operations Committee of the TRA-2P study of vorapaxar. Vorapaxar is one of Merck's investigational cardiovascular medicines.
› Verified 7 days ago